GSK-111053

Study Sponsor: GSK

Study Title

Non-inferiority of co-administration of GSK Biologicals’pneumococcal conjugate vaccine GSK1024850A with DTPa-IPV-Hib versus co-administration with DTPa-HBV-IPV/Hib.

Medicine or Vaccine (generic name)

Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)

Sponsor Identification Number

111053

Trial Registry Identification Number(#'s)

NCT00652951 2007-004002-26

Medical Condition

Infections, Streptococcal

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=110142

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00652951

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-004002-26

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a follow-up study to 110142. The results of this study 111053 are summarised with 110142 on the GSK Study Register.

Date Added to this Site

March 2014